MedTrace Logo

Quebec Lung Cancer Screening PLUS Trial

NCT05444062 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2025-08-11

No results posted yet for this study

Summary

Does an educational intervention for untreated COPD and cardiovascular disease which is integrated in an existing lung cancer screening program improve guideline concordant medication adherence at 12 months

Conditions

  • COPD
  • Coronary Artery Calcification

Interventions

BEHAVIORAL

Educational material and treatment recommendations for patients, general practitioners and pharmacists

Educational material and treatment recommendations given to patients, their family doctors and their pharmacists.

Sponsors & Collaborators

  • Nicole Ezer, MD, FRCPC, MPH

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-23
Primary Completion
2026-02-28
Completion
2027-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05444062 on ClinicalTrials.gov